Summary: Intelligent Living covers our recent announcement about a new MAPS-sponsored study of MDMA-assisted group therapy for PTSD and the importance of communal group therapy sessions for providing significant results.
“MDMA-assisted psychotherapy for PTSD (post-traumatic stress disorder) is possibly the most clinically advanced application in the rapidly expanding field of psychedelic medicine. The therapy technique, which has been promoted for years by the Multidisciplinary Association of Psychedelic Studies (MAPS), is currently undergoing advanced Phase 3 studies with remarkably promising early findings,” explains Luana Steffen of Intelligent Living.